Relapsed/Refractory Hairy Cell Leukemia
Drug | Drug Name | Drug Description |
---|---|---|
DB12688 | Moxetumomab pasudotox | A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB12688 | Moxetumomab pasudotox | B-cell receptor CD22 | target |
DB12688 | Moxetumomab pasudotox | Elongation factor 2 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15699 | Brexucabtagene autoleucel | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB12688 | Moxetumomab pasudotox | Not Available | Approved for Marketing | 1 |